The results of the trial into a new type of smart drug given to Acute Myeloid Leukaemia patients show that GO treatment could improve the effectiveness of chemotherapy without excessively increasing side effects, according to the study.
The study, published in the Journal of Clinical Oncology, said that this may provide a potential lifeline for older AML patients who are often too frail to tolerate more intensive chemotherapy regimes.
More top news
GPs have a public duty to tell authorities if a patient is driving against medical advice, new guidance from the GMC says.
The Government may be about to announce a new levy on council tax of up to 2% to replenish social care budgets.
How do you solve a £4.4 billion hole like tax credits? At 12.30pm on Wednesday, we'll find out.